| PRD_900118 | Name: | 6-O-alpha-D-mannopyranosyl-alpha-D-mannopyranose | Formula: | C12 H22 O11 | Description: | oligosaccharide | Definition date: | 2020-07-29 | Last modified: | 2020-07-29 |
|
| PRD_900119 | Name: | Lewis X antigen, beta anomer | Formula: | C20 H35 N O15 | Description: | oligosaccharide with branches | Definition date: | 2020-07-29 | Last modified: | 2020-07-29 |
|
| PRD_900120 | Name: | Lewis X antigen, alpha anomer | Formula: | C20 H35 N O15 | Description: | oligosaccharide with branches | Definition date: | 2020-07-29 | Last modified: | 2020-07-29 |
|
| PRD_900121 | Name: | Sialyl-Lewis X antigen, beta anomer | Formula: | C31 H52 N2 O23 | Description: | oligosaccharide with branches | Definition date: | 2020-07-29 | Last modified: | 2020-07-29 |
|
| PRD_900122 | Name: | Sialyl-Lewis X antigen, alpha anomer | Formula: | C31 H52 N2 O23 | Description: | oligosaccharide with branches | Definition date: | 2020-07-29 | Last modified: | 2020-07-29 |
|
| PRD_900123 | Name: | Lewis B antigen, beta anomer | Formula: | C26 H45 N O19 | Description: | oligosaccharide with branches | Definition date: | 2020-07-29 | Last modified: | 2020-07-29 |
|
| PRD_900124 | Name: | Lewis Y antigen, alpha anomer | Formula: | C26 H45 N O19 | Description: | oligosaccharide with branches | Definition date: | 2020-07-29 | Last modified: | 2020-07-29 |
|
| PRD_900125 | Name: | H type 2 antigen, alpha anomer | Formula: | C20 H35 N O15 | Description: | oligosaccharide | Definition date: | 2020-07-29 | Last modified: | 2020-07-29 |
|
| PRD_900126 | Name: | Blood group A Lewis B antigen, beta anomer | Formula: | C34 H58 N2 O24 | Description: | oligosaccharide with branches | Definition date: | 2020-07-29 | Last modified: | 2020-07-29 |
|
| PRD_900127 | Name: | Blood group A Lewis Y antigen, beta anomer | Formula: | C34 H58 N2 O24 | Description: | oligosaccharide with branches | Definition date: | 2020-07-29 | Last modified: | 2020-07-29 |
|
| PRD_900128 | Name: | Blood group A Lewis Y antigen, alpha anomer | Formula: | C34 H58 N2 O24 | Description: | oligosaccharide with branches | Definition date: | 2020-07-29 | Last modified: | 2020-07-29 |
|
| PRD_001133 | Name: | (2R,6S,13aR,14aR,16aS)-6-{[(cyclopentyloxy)carbonyl]amino}-14a-[(cyclopropylsulfonyl)carbamoyl]-5,16-dioxooctadecahydrocyclopropa[e]pyrrolo[1,2-a][1,4]diazacyclopentadecin-2-yl 3,4-dihydroisoquinoline-2(1H)-carboxylate | Formula: | C37 H51 N5 O9 S | Definition date: | 2013-08-07 | Last modified: | 2020-07-20 |
|
| PRD_002374 | Name: | cyclic trypsin inhibitor | Formula: | C66 H106 N18 O18 | Definition date: | 2020-07-01 | Last modified: | 2020-07-02 |
|
| PRD_002375 | Name: | cyclic trypsin inhibitor | Formula: | C69 H109 N21 O18 | Definition date: | 2020-07-01 | Last modified: | 2020-07-02 |
|
| PRD_002127 | Name: | N-[4-(hydroxymethyl)benzoyl]-beta-alanyl-3-(8-phenyloctyl)-L-histidyl-L-seryl-O-phosphono-L-threoninamide | Formula: | C38 H54 N7 O11 P | Definition date: | 2014-12-03 | Last modified: | 2020-06-27 |
|
| PRD_002270 | Name: | N-{(3R,6S,9S,12R)-6-ethyl-12-methyl-9-[3-(N'-methylcarbamimidamido)propyl]-2,5,8,11-tetraoxo-3-phenyl-1,4,7,10-tetraazacyclotetradecan-12-yl}-2-methylpropanamide | Formula: | C28 H44 N8 O5 | Definition date: | 2017-06-28 | Last modified: | 2020-06-21 |
|
| PRD_002393 | Name: | UAW247 | Formula: | C24 H27 N3 O5 | Definition date: | 2020-06-17 | Last modified: | 2020-06-17 |
|
| PRD_002347 | Name: | ~{N}-[(2~{S})-3-cyclohexyl-1-oxidanylidene-1-[[(2~{S})-1-oxidanylidene-3-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]propan-2-yl]amino]propan-2-yl]-1~{H}-indole-2-carboxamide | Formula: | C25 H32 N4 O4 | Definition date: | 2020-06-03 | Last modified: | 2020-06-03 |
|
| PRD_002349 | Name: | ~{N}-[(2~{S})-3-(3-fluorophenyl)-1-oxidanylidene-1-[[(2~{S})-1-oxidanylidene-3-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]propan-2-yl]amino]propan-2-yl]-1~{H}-indole-2-carboxamide | Formula: | C25 H25 F N4 O4 | Definition date: | 2020-06-03 | Last modified: | 2020-06-03 |
|
| PRD_002385 | Name: | Papain-like protease peptide inhibitor VIR250 | Formula: | C23 H32 N6 O6 S | Definition date: | 2020-05-20 | Last modified: | 2020-05-20 |
|
| PRD_002382 | Name: | boceprevir (bound form) | Formula: | C27 H47 N5 O5 | Definition date: | 2020-05-06 | Last modified: | 2020-05-06 |
|
| PRD_001136 | Name: | SUGAR (6-MER) | Formula: | C57 H82 O26 | Description: | Chromomycin A3 is an anthraquinone. It is a glycosidic antibiotic produced at the fermentation of a strain of Streptomyces griseus. It is also called toyomycin. | Definition date: | 2013-07-26 | Last modified: | 2020-04-04 |
|
| PRD_002326 | Name: | Phosphinic inhibitor DG014 | Formula: | C62 H91 N9 O18 P | Definition date: | 2019-12-18 | Last modified: | 2019-12-18 |
|
| PRD_002357 | Name: | SHV-WFP-SER-PRO-YCP-ALA-MP8 Acyldepsipeptide | Formula: | C39 H54 F2 N6 O8 | Definition date: | 2019-11-06 | Last modified: | 2019-11-06 |
|
| PRD_002359 | Name: | OO1-WFP-SER-PRO-YCP-ALA-MP8 ureadepsipeptide | Formula: | C40 H49 F2 N7 O8 | Definition date: | 2019-11-06 | Last modified: | 2019-11-06 |
|